Catalyst Wire Dossier Catalyst Wire Dossier

Vigadexa

moxifloxacin/dexamethasone ophthalmic suspension · Alcon Research
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Vigadexa, covering 2010-02-15 to 2013-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients [Phase 4]

See pricing